Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial. (nature.com)

Authors: Paul G … Barker RA Journal: Nature Medicine Published: 2026-07-09 DOI: https://doi.org/10.1038/s41591-026-04525-0